With the increasing need for effective drug development for chronic diseases, collaborations and partnerships between private and public sectors...

Recently, open science has been making major strides in the news. Sure, people have been clamoring for full disclosure and availability of journal...

“The $1000 Pill.” “The Quest: $84,000 Miracle Cure Costs Less Than $150 to Make.” “A Billion a Year for Costly Drug Treatment.” These eye-catching...

In the Age of the Microbiome blog post which initiated this series we introduced the spectacular potential that the microbiome offers for drug...

Elena Simon is just an average teenage girl, one who enjoys dancing and acting, and plans on attending Harvard in the fall to study computer...

DNA has often been likened to a book, with a set of instructions written in A’s, T’s, C’s, and G’s. But even if the contents of the book are known...

Outsourcing drug discovery and development has become the key to making the entire drug research process more efficient. Over the past few years...

We recently talked about how Green Fluorescent Protein, restriction enzymes, and CRISPR are invaluable products of basic research. These...

The Fermanian School of Business and the Fermanian Business and Economic Institute held their annual Business Breakfast honoring the Dealmakers of...

Over the course of the last century we’ve had the age of antibiotics, the genetic revolution, transplantation and immunotherapy, each of which...